Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDICT: Citrullinemia for Enteral Nutrition Tolerance in ICU
NCT03967795Completed
- Sponsor
- CHU de Besançon
- Start
- Nov 2019
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHU de Besançon. Primary endpoint: Feeding intolerance at day-3 and citrulline generation test. Started Nov 2019; status: completed.
Beyond the preview
Go deeper on NCT03967795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03967795.